Breast Cancer: Monitoring Response to Neoadjuvant Chemotherapy Using Tc-99m Sestamibi Scintimammography

Publisher： Karger

E-ISSN： 2296-5262|26|1|27-31

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.1, 2003-03, pp. : 27-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection and Prediction of Breast Cancer Using Double Phase Tc-99m MIBI Scintimammography in Comparison with MRI

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 556-560

Karger

Access to resources Recommend Favorite

Determination and Prediction of P-Glycoprotein and Multidrug-Resistance-Related Protein Expression in Breast Cancer with Double-Phase Technetium-99m Sestamibi Scintimammography

By  

Oncology, Vol. 70, Iss. 6, 2007-02 ,pp. : 403-410

Karger

Access to resources Recommend Favorite

Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 5, 2015-11 ,pp. : 1407-1420

John Wiley & Sons Inc

Access to resources Recommend Favorite

The utility of 99m Tc-sestamibi scintigraphy in the localisation of parathyroid adenomas in primary hyperparathyroidism

By Glynn N.  

Irish Journal of Medical Science, Vol. 180, Iss. 1, 2011-03 ,pp. : 191-194

Springer Publishing Company

Access to resources Recommend Favorite

Electrocardiographic Gated 99mTc-Sestamibi SPECT Immediately after Primary Percutaneous Coronary Intervention Characterizes Reperfusion Success

By  

Cardiology, Vol. 99, Iss. 4, 2003-07 ,pp. : 198-204

Karger

Access to resources Recommend Favorite